United States - Baltimore Longitudinal Study of Aging (BLSA) Data System Development and Data Science Consulting

Description

Added: Apr 05, 2019 3:03 pm

This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued.
The solicitation number is HHS-NIH-NIDA(AG)-RFP-75N95019R00020 and the solicitation is issued as a request for proposals (RFP).
This acquisition is for a commercial item or service and is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13-Simplified Acquisition Procedures; FAR Subpart 13.5- Simplified Procedures for Certain Commercial Items; and FAR Part 12-Acquisition of Commercial Items, and is expected to exceed the simplified acquisition threshold.
The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2019-01, dated January 2019.
The associated NAICS code is 541690 and the small business size standard is $15,000,000. This requirement is being solicited as full and open with no set-aside restrictions.
Description:
The purpose of this requirement is to obtain methodological and technical expertise in data science in order to develop a comprehensive modern data system for the Baltimore Longitudinal Study of Aging (BLSA). This new data system will facilitate the collection, storage, integration, and maintenance of BLSA data as well as improve data documentation and access for both intramural and extramural investigators.
Background:
The BLSA is a unique and invaluable resource on human aging, begun in 1958, it is a continuously enrolled cohort study of community dwelling adults that seeks to evaluate change in medical, physiological, cognitive and physical function across the adult life span. In the modern era of the study, participants are enrolled and return at regular intervals for study visits that include a wide range of testing: standard clinical assessments, specialized research instruments, laboratory tests, imaging studies, genomic panels as well as other evaluations. The study database also incorporates historical data gathered from a range of protocols over the 60 year history of the study. The BLSA encompasses a large variety of multi-dimensional data that has been managed in a siloed manner driven by topic area. Data science services are required to create a system for BLSA data processes that is cohesive, uniform, and inclusive.

Purpose and Objectives:
Please see attachment titled "HHS-NIH-NIDA(AG)-RFP-75N95019R00020_BLSA Data System"
Project Requirements:
Please see attachment titled "HHS-NIH-NIDA(AG)-RFP-75N95019R00020_BLSA Data System"
Deliverables and Reporting Requirements:
Please see attachment titled "HHS-NIH-NIDA(AG)-RFP-75N95019R00020_BLSA Data System"
Government Responsibilities:
Please see attachment titled "HHS-NIH-NIDA(AG)-RFP-75N95019R00020_BLSA Data System"
Technical Evaluation Criteria:
Please see attachment titled "HHS-NIH-NIDA(AG)-RFP-75N95019R00020_BLSA Data System"

Place of Performance:
Inspection and acceptance will be performed at:
3001 S. Hanover Street
Baltimore, Maryland 21225
United States
FAR clause 52.212-1, Instructions to Offerors - Commercial Items, applies to this acquisition.

FAR clause 52.212-2, Evaluation - Commercial Items, applies to this acquisition.
(a) The Government will award a contract resulting from this solicitation to the responsible offeror whose offer conforming to the solicitation will be most advantageous to the Government, price and other factors considered.

(b) Options. The Government will evaluate offers for award purposes by adding the total price for all options to the total price for the basic requirement. The Government may determine that an offer is unacceptable if the option prices are significantly unbalanced. Evaluation of options shall not obligate the Government to exercise the option(s).
(c) A written notice of award or acceptance of an offer, mailed or otherwise furnished to the successful offeror within the time for acceptance specified in the offer, shall result in a binding contract without further action by either party. Before the offer's specified expiration time, the Government may accept an offer (or part of an offer), whether or not there are negotiations after its receipt, unless a written notice of withdrawal is received before award.
The Offerors to include a completed copy of the provision at FAR clause 52.212-3, Offeror Representations and Certifications-Commercial Items, with its offer.
FAR clause at 52.212-4, Contract Terms and Conditions - Commercial Items, applies to this acquisition.
FAR clause at 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders-Commercial Items, applies to this acquisition.
Please see attachment titled "HHS-NIH-NIDA(AG)-RFP-75N95019R00020_BLSA Data System" for additional contract requirement(s) or terms and conditions as determined by the contracting officer are necessary for this acquisition and consistent with customary commercial practices.
The Defense Priorities and Allocations System (DPAS) are not applicable to this requirement.
Responses to this solicitation must include clear and convincing evidence of the offeror's capability of fulfilling the requirement as it relates to the technical evaluation criteria. The business proposal must contain sufficient information to allow the Government to perform a basic analysis of the proposed cost or price of the work.
In addition the Dun & Bradstreet Number (DUNS), the Taxpayer Identification Number (TIN), and the certification of business size must be included in the response. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov."
All responses must be received by 4:00 P.M. Eastern time on May 03, 2019 and reference number HHS-NIH-NIDA(AG)-RFP-75N95019R00020. Responses may be submitted electronically to Eric McKay, eric.mckay@nih.gov.
Fax responses will not be accepted
Primary Point of Contact.:
Eric McKay,
Contract Specialist
eric.mckay@nih.gov
Phone: 301-480-2406

Opportunity closing date

03 May 2019

Value of contract

to be confirmed